Geron (GERN) News Today $2.89 -0.03 (-1.03%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Geron Corporation (GERN) Stock: An Under $5 Gem with Biggest Upside PotentialJanuary 20 at 11:03 PM | insidermonkey.comGeron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO SalesJanuary 16, 2025 | seekingalpha.comGeron (GERN) Receives a Buy from BarclaysJanuary 15, 2025 | markets.businessinsider.comGeron (NASDAQ:GERN) Stock Price Down 8.5% - Time to Sell?Geron (NASDAQ:GERN) Stock Price Down 8.5% - Here's What HappenedJanuary 15, 2025 | marketbeat.comStrong Growth and Strategic Financial Management Bolster Buy Rating for Geron’s Promising Rytelo DrugJanuary 15, 2025 | markets.businessinsider.comGeron’s Promising Market Growth: Strong Sales Performance and Optimistic Financial GuidanceJanuary 14, 2025 | markets.businessinsider.comNeedham & Company LLC Raises Geron (NASDAQ:GERN) Price Target to $7.00January 14, 2025 | americanbankingnews.comGeron Corporation: Strong Market Performance and Strategic Advancements Justify Buy Rating and Increased Price TargetJanuary 13, 2025 | markets.businessinsider.comGeron (NASDAQ:GERN) Trading Down 8.5% - Time to Sell?Geron (NASDAQ:GERN) Shares Down 8.5% - Should You Sell?January 13, 2025 | marketbeat.comNeedham & Company LLC Issues Positive Forecast for Geron (NASDAQ:GERN) Stock PriceNeedham & Company LLC upped their price objective on shares of Geron from $6.00 to $7.00 and gave the company a "buy" rating in a report on Monday.January 13, 2025 | marketbeat.comFY2024 Earnings Forecast for Geron Issued By Leerink PartnrsGeron Co. (NASDAQ:GERN - Free Report) - Analysts at Leerink Partnrs lowered their FY2024 EPS estimates for Geron in a note issued to investors on Monday, January 6th. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will post earnings per share of ($0.29) forJanuary 8, 2025 | marketbeat.comGeron Inc.: Strategic Updates and Revised Launch Estimates Reinforce Buy RatingJanuary 8, 2025 | markets.businessinsider.comLeerink Partnrs Brokers Lower Earnings Estimates for GeronGeron Co. (NASDAQ:GERN - Free Report) - Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Geron in a note issued to investors on Monday, January 6th. Leerink Partnrs analyst F. Khurshid now expects that the biopharmaceutical company will post earnings per sharJanuary 7, 2025 | marketbeat.comIs Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?January 1, 2025 | insidermonkey.comGeron (NASDAQ:GERN) Trading 4.4% Higher - Here's What HappenedGeron (NASDAQ:GERN) Shares Up 4.4% - Time to Buy?December 31, 2024 | marketbeat.comGeron (GERN) Stock Surges on Game-Changing New TreatmentDecember 30, 2024 | tipranks.comGeron Corp. (GERN) Ends Trading Week Defying Market BloodbathDecember 28, 2024 | insidermonkey.comGeron Co. (NASDAQ:GERN) Receives Consensus Rating of "Buy" from AnalystsGeron Co. (NASDAQ:GERN - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and twoDecember 27, 2024 | marketbeat.comIs Geron Corp. (GERN) the Biggest Loser of This Week?December 26, 2024 | insidermonkey.comGeode Capital Management LLC Increases Holdings in Geron Co. (NASDAQ:GERN)Geode Capital Management LLC grew its stake in Geron Co. (NASDAQ:GERN - Free Report) by 1.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,067,999 shares of the biopharmaceutical company's stock afteDecember 22, 2024 | marketbeat.comGeron (NASDAQ:GERN) Stock Price Down 2.5% - Here's WhyGeron (NASDAQ:GERN) Trading Down 2.5% - What's Next?December 20, 2024 | marketbeat.comBarclays PLC Has $5.90 Million Stock Holdings in Geron Co. (NASDAQ:GERN)Barclays PLC increased its holdings in shares of Geron Co. (NASDAQ:GERN - Free Report) by 114.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,299,912 shares of the biopharmaceutical company's stock after buying an additionDecember 20, 2024 | marketbeat.comGeron Corp (GERN) Grants Stock Options to New EmployeesDecember 19, 2024 | gurufocus.comGeron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72%December 18, 2024 | finance.yahoo.comGeron (NASDAQ:GERN) Stock Price Up 3.7% - Here's WhyGeron (NASDAQ:GERN) Trading 3.7% Higher - Should You Buy?December 17, 2024 | marketbeat.comGeron Co. (NASDAQ:GERN) Short Interest Down 5.4% in NovemberGeron Co. (NASDAQ:GERN - Get Free Report) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 66,350,000 shares, a drop of 5.4% from the November 15th total of 70,130,000 shares. Based on an average daily trading volume, of 8,070,000 shares, the days-to-cover ratio is currently 8.2 days.December 17, 2024 | marketbeat.comGeron Co. (NASDAQ:GERN) Shares Sold by MML Investors Services LLCMML Investors Services LLC cut its stake in Geron Co. (NASDAQ:GERN - Free Report) by 35.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 551,168 shares of the biopharmaceutical company's stock after selling 300,060 sharesDecember 16, 2024 | marketbeat.comState Street Corp Grows Holdings in Geron Co. (NASDAQ:GERN)State Street Corp boosted its holdings in shares of Geron Co. (NASDAQ:GERN - Free Report) by 28.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 28,961,671 shares of the biopharmaceutical company's stock after purchasing an additional 6,413,204 sharesDecember 15, 2024 | marketbeat.comExome Asset Management LLC Invests $4.11 Million in Geron Co. (NASDAQ:GERN)Exome Asset Management LLC purchased a new stake in Geron Co. (NASDAQ:GERN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 905,126 shares of the biopharmaceutical company's stock, valued atDecember 14, 2024 | marketbeat.comBuy Rating on Geron Driven by EU Approval Prospects and Strategic Commercialization of RyteloDecember 14, 2024 | markets.businessinsider.comGeron (NASDAQ:GERN) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $6.00 price objective on shares of Geron in a report on Friday.December 13, 2024 | marketbeat.comGeron Gets Positive CHMP Opinion For RYTELO In Transfusion-Dependent Anemia Due To Lower-Risk MDSDecember 13, 2024 | markets.businessinsider.comWorld Investment Advisors LLC Buys 1,019,510 Shares of Geron Co. (NASDAQ:GERN)World Investment Advisors LLC raised its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 10,151.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,029,553 shares of the biopharmaceutical company's stockDecember 13, 2024 | marketbeat.comGeron announces positive CHMP opinion for RyteloDecember 13, 2024 | tipranks.comGeron Corp (GERN) Receives Positive CHMP Opinion for RYTELO in Treating Blood CancerDecember 13, 2024 | gurufocus.comGeron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDSDecember 13, 2024 | businesswire.comGeron Co. (NASDAQ:GERN) Shares Bought by Wellington Management Group LLPWellington Management Group LLP raised its position in Geron Co. (NASDAQ:GERN - Free Report) by 4.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,662,404 shares of the biopharmaceutical company'December 12, 2024 | marketbeat.comGeron (GERN) Gets a Buy from Stifel NicolausDecember 11, 2024 | markets.businessinsider.comBarclays Issues a Buy Rating on Geron (GERN)December 11, 2024 | markets.businessinsider.comGeron (GERN) Receives a Buy from TD CowenDecember 11, 2024 | markets.businessinsider.comFY2026 Earnings Forecast for Geron Issued By Leerink PartnrsGeron Co. (NASDAQ:GERN - Free Report) - Research analysts at Leerink Partnrs lifted their FY2026 EPS estimates for shares of Geron in a note issued to investors on Sunday, December 8th. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will earn $0.36 per sharDecember 11, 2024 | marketbeat.comBNP Paribas Financial Markets Boosts Stock Holdings in Geron Co. (NASDAQ:GERN)BNP Paribas Financial Markets raised its holdings in shares of Geron Co. (NASDAQ:GERN - Free Report) by 519.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 205,332 shares of the biopharmaceutical company's sDecember 11, 2024 | marketbeat.comIs Geron Corporation (GERN) the Best NASDAQ Penny Stock to Buy Right Now?December 11, 2024 | insidermonkey.comAnalyst Scoreboard: 4 Ratings For GeronDecember 10, 2024 | benzinga.comGeron (NASDAQ:GERN) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $9.00 price objective on shares of Geron in a research note on Tuesday.December 10, 2024 | marketbeat.comScotiabank Reaffirms Their Buy Rating on Geron (GERN)December 9, 2024 | markets.businessinsider.comThe Manufacturers Life Insurance Company Has $3.16 Million Stock Position in Geron Co. (NASDAQ:GERN)The Manufacturers Life Insurance Company cut its stake in shares of Geron Co. (NASDAQ:GERN - Free Report) by 24.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 695,535 shares of the biopharmaceuticalDecember 8, 2024 | marketbeat.comFmr LLC Sells 376,720 Shares of Geron Co. (NASDAQ:GERN)Fmr LLC trimmed its holdings in Geron Co. (NASDAQ:GERN - Free Report) by 2.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,979,056 shares of the biopharmaceutical company's stock after selling 376,720 shares during the quDecember 7, 2024 | marketbeat.comRA Capital Management L.P. Lowers Position in Geron Co. (NASDAQ:GERN)RA Capital Management L.P. cut its holdings in Geron Co. (NASDAQ:GERN - Free Report) by 30.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,285,755 shares of the biopharmaceutical company's stock aftDecember 5, 2024 | marketbeat.com44,111,916 Shares in Geron Co. (NASDAQ:GERN) Bought by RTW Investments LPRTW Investments LP acquired a new position in shares of Geron Co. (NASDAQ:GERN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 44,111,916 shares of the biopharmaceutical company's stock, valDecember 5, 2024 | marketbeat.com Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address GERN Media Mentions By Week GERN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERN News Sentiment▼0.860.44▲Average Medical News Sentiment GERN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERN Articles This Week▼76▲GERN Articles Average Week Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HALO News Today MDGL News Today IONS News Today ALKS News Today FOLD News Today LGND News Today MNKD News Today DVAX News Today CLDX News Today BCRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GERN) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geron Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Geron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GERN Stock Alerts